Centre for Cancer Prevention
Browse by
The Centre for Cancer Prevention conducts research into the prevention of cancer with particular focus on preventive therapy and screening.
Recent Submissions
-
Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study
(SAGE Publications, 2021-09)Objective The NHS Cervical Screening Programme plans to increase the screening interval from 3 to 5 years for women aged 25–49 who test negative for human papillomavirus (HPV). This exploratory cross-sectional online ... -
Short-term psychosocial outcomes of adding a non-contrast abdominal computed tomography (CT) scan to the thoracic CT within lung cancer screening.
(2024-05)OBJECTIVES: To evaluate psychological, social, and financial outcomes amongst individuals undergoing a non-contrast abdominal computed tomography (CT) scan to screen for kidney cancer and other abdominal malignancies ... -
Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
(2024-04)BACKGROUND: Trials are underway to test the clinical utility of multi-cancer early detection (MCED) blood tests for screening asymptomatic individuals. We sought to understand the acceptability of MCED blood test screening ... -
The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: a systematic review and meta-analysis.
(Taylor & Francis, 2023-12-21)INTRODUCTION: The number of patients desiring fertility-preserving treatment for endometrial cancer rather than standard surgical management continues to increase. OBJECTIVE: We aimed to evaluate the efficacies of ... -
Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study.
(2024-01-04)BACKGROUND: Even though the incidence of Multisystem Inflammatory Syndrome in children (MIS-C) is decreasing cases are still reported across the world. Studying the consequences of MIS-C enhances our understanding of the ... -
Segmental ischemia and indocyanine green navigation: impact on perioperative parameters in laparoscopic vs. open partial nephrectomy
(2023-01-01)The aim of this study is to compare perioperative parameters of laparoscopic partial nephrectomy and open partial nephrectomy in renal tumor management, and to evaluate the effect of using novel method of indocyanine green ... -
BRCA awareness and testing experience in the UK Jewish population: a qualitative study
(BMJ Publishing Group, 04-04-2024)Background 1 in 40 UK Jewish individuals carry a pathogenic variant in BRCA1/BRCA2. Traditional testing criteria miss half of carriers, and so population genetic testing is being piloted for Jewish people in England. There ... -
Should I Take Aspirin? (SITA): RCT of a decision aid for cancer chemoprevention.
(2024-03-25)Background Australian guidelines recommend that all people aged 50-70 years old consider taking low-dose aspirin to reduce the risk of colorectal cancer (CRC). Aim To determine the effect of a consultation with a researcher ... -
Audit on the use of core biopsy imprint cytology in a one stop Breast clinic
(Elsevier, 2024-02) -
Screening and prevention of ovarian cancer.
(2024-02-14)Ovarian cancer remains the most lethal gynaecological malignancy with 314 000 cases and 207 000 deaths annually worldwide. Ovarian cancer cases and deaths are predicted to increase in Australia by 42% and 55% respectively ... -
Comparing accuracy of tomosynthesis plus digital mammography or synthetic 2D mammography in breast cancer screening: baseline results of the MAITA RCT consortium.
(2024-03)AIM: The analyses here reported aim to compare the screening performance of digital tomosynthesis (DBT) versus mammography (DM). METHODS: MAITA is a consortium of four Italian trials, REtomo, Proteus, Impeto, and MAITA ... -
Complement system genetic variability shapes pancreatic cancer risk
(Elsevier, 2023-11) -
The cost-effectiveness of risk-stratified breast cancer screening in the UK.
(2023-11)BACKGROUND: There has been growing interest in the UK and internationally of risk-stratified breast screening whereby individualised risk assessment may inform screening frequency, starting age, screening instrument used, ...